Evolus, Inc.
Company Stats
- Market Cap
- $528.4M
- as of Sep 30, 2026
- Enterprise Value
- $624.6M
- Shares Outstanding
- 66.1M
- Free Float
- 76.5%
Income Statement
- Revenue
- $297.2M
- Operating Income
- -$32.7M
- Net Income
- -$51.6M
- EBITDA
- -$25.2M
- Revenue Growth, 3Y
- 26.0%
- FCF Margin, 3Y Avg
- -13.3%
- FCF Margin, Worst Year
- -17.1%
Cash Flow
- Free Cash Flow
- -$45.7M
- FCF Yield
- -8.6%
- Owner FCF Yield
- -12.6%
Balance Sheet
- Cash & Equivalents
- $53.8M
- Total Debt
- $150.0M
- Net Debt
- $96.2M
Returns & Capital
- SBC, 3Y Avg
- $19.8M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $297.2M | -$45.7M | -15.4% |
| FY2024 | $266.3M | -$19.5M | -7.3% |
| FY2023 | $202.1M | -$34.5M | -17.1% |
| FY2022 | $148.6M | -$86.5M | -58.2% |
| FY2021 | $99.7M | -$33.8M | -33.9% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 31, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Healthcare Earnings: Demand Surges, Costs Bite Back